Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3093653rdf:typepubmed:Citationlld:pubmed
pubmed-article:3093653lifeskim:mentionsumls-concept:C0023005lld:lifeskim
pubmed-article:3093653lifeskim:mentionsumls-concept:C0017562lld:lifeskim
pubmed-article:3093653lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:3093653lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:3093653lifeskim:mentionsumls-concept:C0012472lld:lifeskim
pubmed-article:3093653lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:3093653lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:3093653lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:3093653lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:3093653lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:3093653lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:3093653pubmed:issue6lld:pubmed
pubmed-article:3093653pubmed:dateCreated1986-11-18lld:pubmed
pubmed-article:3093653pubmed:abstractTextThe effect of human and murine gamma interferon (IFN-gamma) on Class II (DR and DQ) expression by human gingival Langerhans cells (LC) was examined using an organ culture system. Human and murine IFN-gamma increased the expression of both DR and DQ antigens during a 72-h period. Maximal levels of DR expression (100% of T6+ cells) were produced within 6 h of IFN-gamma treatment and were maintained during culture. DQ expression was maximal (100% of T6+ cells) at 18 h and was more labile than DR. The effect of IFN-gamma on DR and DQ was abrogated by prostaglandin E2 (PGE) while indomethacin, and inhibitor of PGE synthesis, mimicked the effect of IFN-gamma on DR and DQ expression. Gingival keratinocytes maintained their expression of DR for 72 h in the presence of gamma-IFN, but did not express DQ under any of the culture conditions used in this study. These results demonstrate that gamma-IFN induces differential expression of Class II antigens in the oral mucosa in vitro, and suggest that gamma-IFN and PGE may be involved in the control of DR and DQ antigen expression in vivo.lld:pubmed
pubmed-article:3093653pubmed:languageenglld:pubmed
pubmed-article:3093653pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3093653pubmed:citationSubsetDlld:pubmed
pubmed-article:3093653pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3093653pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3093653pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3093653pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3093653pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3093653pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3093653pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3093653pubmed:statusMEDLINElld:pubmed
pubmed-article:3093653pubmed:monthJullld:pubmed
pubmed-article:3093653pubmed:issn0300-9777lld:pubmed
pubmed-article:3093653pubmed:authorpubmed-author:SeymourG JGJlld:pubmed
pubmed-article:3093653pubmed:authorpubmed-author:PowellR NRNlld:pubmed
pubmed-article:3093653pubmed:authorpubmed-author:WalshL JLJlld:pubmed
pubmed-article:3093653pubmed:issnTypePrintlld:pubmed
pubmed-article:3093653pubmed:volume15lld:pubmed
pubmed-article:3093653pubmed:ownerNLMlld:pubmed
pubmed-article:3093653pubmed:authorsCompleteYlld:pubmed
pubmed-article:3093653pubmed:pagination347-51lld:pubmed
pubmed-article:3093653pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:meshHeadingpubmed-meshheading:3093653-...lld:pubmed
pubmed-article:3093653pubmed:year1986lld:pubmed
pubmed-article:3093653pubmed:articleTitleModulation of class II (DR and DQ) antigen expression on gingival Langerhans cells in vitro by gamma interferon and prostaglandin E2.lld:pubmed
pubmed-article:3093653pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3093653pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3093653lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3093653lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3093653lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3093653lld:pubmed